Journals / Klinik Tıp Bilimleri / 2019 / Cilt: 7 - Sayı: 3

Type 2 Diabetes Treatment With Oral Antidiabetic Drugs

Tip 2 Diyabetin Oral Antidiyabetik İlaçlarla Tedavisi

Pages
20–23
Publication Date
2019-04-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we are going to summarize the place of oral antidiabetic agents intreatment of type 2 diabetes mellitus and the principles of treatment approaches in thelight of current knowledge.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractType 2 diabetes mellitus is a chronic disease which is especially characterized by insulin resistance .
📊
Key Findings & Data:Type 2 diabetes should be treated well because of the increasing in ıtsprevalence with resulting high cost or constituting both acute and chronic complications.
💡
Conclusion & Impact:In this article, we are going to summarize the place of oral antidiabetic agents intreatment of type 2 diabetes mellitus and the principles of treatment approaches in thelight of current knowledge.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:diyabetes mellitus · günceltedavi · oral antidiyabetikilaçlar

Abstract

AbstractType 2 diabetes mellitus is a chronic disease which is especially characterized by insulin resistance . Type 2 diabetes should be treated well because of the increasing in ıtsprevalence with resulting high cost or constituting both acute and chronic complications. The goal of treatment is to achieve glycemic control and prevention of complications. In this article, we are going to summarize the place of oral antidiabetic agents intreatment of type 2 diabetes mellitus and the principles of treatment approaches in thelight of current knowledge.

Özet

Öz Tip 2 diabetes mellitus özellikle insülin direnci ile karakterize kronik bir hastalıktır.Tip 2 diyabetin prevalansındaki artış ve bundan dolayı oryata çıkan yüksek maliyet birlikte akut ya da kronik dönemde oluşturduğu komplikasyonları nedeniyle iyi tedavi edilmelidir. Tedavide amaç glisemik kontrolün sağlanması ve komplikasyonların önlenmesidir. Bu makalede tip 2 diyabetin tedavisinde oral antidiyabetik ajanların yeri ve tedavi ilkeleri ilgili yaklaşımlar güncel bilgiler ışığında özetlenecektir.

🔖

Cite This Article

SALMANOĞLU, Y. D. D. M. (2019). Type 2 Diabetes Treatment With Oral Antidiabetic Drugs. Klinik Tıp Bilimleri, Cilt: 7 - Sayı: 3, 20–23. https://ajindex.com/articles/838220

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Kaynaklar 1.Türkiye Endokrinoloji ve Metabolizma Derneği, Diabetes mel-litus ve komplikasyonlarının tanı, tedavi ve izlem klavuzu-2015. 2.Satman İ, TURDEP I Group: D Care 2002
  2. 6 3.İ Satman ve TURDEP II Çalışma Grubu,2010 4.American Diabetes Association. Standards of medical care indiabetes-2014. Diabetes Care. 2015
  3. 38 (Suppl 1):S8-S16 5.Diabetes Mellitus Tanı ve Tedavisinde Güncel Durum, İç has-talıkları Dergisi 2011
  4. UK Prospective Diabetes Study Group. Intensive blood-glu-cose control with sulphonylureas or insulin compared with con-ventional treatment and risk of complications in patients withtype 2 diabetes (UKPDS 33). Lancet. 352:837–853, 1998. 7.Goodarzi MO, Bryer-Ash M. Metformin revisited: re- evalua-tion of its properties and role in the pharmacopoeia of modernantidiabetic agents. Dabetes Obes Metab, 7: 654-665, 2005. 8.Wood MJ, Bailey CJ. Making a case for inclusion of new oralanti-diabetic agents in drug formularies. Pract Diab Ġnt, 17:141-146, 2000. 9.Cefalu WT, Bakris G, Blonde L et al. Standards of Medical Carein Diabetes. Diabetes Care 2015
  5. 38(1):1-90. 10.Drucker DJ, Nauck MA. The increatin system: glucagon-likepeptide 1 receptör agonists and dipeptidyl peptidase-4 inhi-bitors in type 2diabetes.Lancet2006
  6. Türkiye Endokrinoloji ve Metabolizma Derneği, Diabetes mel-litus ve komplikasyonlarının tanı, tedavi ve izlem klavuzu-2015.